DURHAM, N.C., September 05, 2018 — As global, multi-center medical device studies become more common, trial monitoring becomes more complex. At a live webcast on Wednesday, September 12 (11 a.m. EDT / 4 p.m. BST / 5 p.m. CEST), Premier Research will examine what it takes to ensure compliance with federal regulations, sponsor agreements, investigational plans, and the rules established by institutional review boards.
Topics will include:
- The role of data monitoring and clinical endpoint committees in ensuring compliance and proper monitoring.
- How the right CRO can help effectively leverage the work of these oversight groups.
- Selection of qualified monitors to ensure patient safety.
Register today to attend Decoding the Distinctions: DMCs, CECs, and Their Role in Medical Research.
About Premier Research
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. The company applies a relentless focus on quality in the execution of global, regional, and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical devices, neuroscience, oncology, pediatrics, and rare disease. Premier Research operates in 84 countries and employs 1,250 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that transform breakthrough biotech thinking into reality.